Abstract
Ventilator-associated pneumonia (VAP) is a common complication in intubated and mechanically ventilated patients. A tracheostomy has been suggested to benefit patients with prolonged need for mechanical ventilation and may protect against VAP. However, a causal relationship between tracheostomy and VAP has also been suggested. This manuscript reviews the literature regarding the (causal) relationship between tracheostomy and VAP in adult critically ill patients.
Keywords: Ventilator associated pneumonia, tracheostomy, risk factors, timing, outcome
Current Respiratory Medicine Reviews
Title: Tracheostomy - Causative or Preventive for Ventilator-Associated Pneumonia?
Volume: 6 Issue: 1
Author(s): Denise P. Veelo, Jan M. Binnekade and Marcus J. Schultz
Affiliation:
Keywords: Ventilator associated pneumonia, tracheostomy, risk factors, timing, outcome
Abstract: Ventilator-associated pneumonia (VAP) is a common complication in intubated and mechanically ventilated patients. A tracheostomy has been suggested to benefit patients with prolonged need for mechanical ventilation and may protect against VAP. However, a causal relationship between tracheostomy and VAP has also been suggested. This manuscript reviews the literature regarding the (causal) relationship between tracheostomy and VAP in adult critically ill patients.
Export Options
About this article
Cite this article as:
Veelo P. Denise, Binnekade M. Jan and Schultz J. Marcus, Tracheostomy - Causative or Preventive for Ventilator-Associated Pneumonia?, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820476
DOI https://dx.doi.org/10.2174/157339810790820476 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Evolution of Diagnosis and Management of Pediatric Biliary Tract Rhabdomyosarcoma
Current Pediatric Reviews Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Pharmacologic Activation of p53 by Small-Molecule MDM2 Antagonists
Current Pharmaceutical Design Manipulating the Ability of Substituted Titanocene Derivatives to Induce Apoptosis in Castrate-Resistant Prostate Cancer Cells
Letters in Drug Design & Discovery Rapidly Increasing Trends in Oropharyngeal Carcinoma Assessed by Worldwide Epidemiologic Analysis
Current Cancer Therapy Reviews Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Mesenchymal Stem Cells Regulate Cytoskeletal Dynamics and Promote Cancer Cell Invasion Through Low Dose Nitric Oxide
Current Molecular Medicine PET Imaging with [<sup>68</sup>Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluoroethylcholine
Current Cancer Drug Targets A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer
Current Pharmaceutical Design Adenoviral Vectors for Cancer Gene Therapy
Current Genomics Bioinformatics Analysis of Functional Relations Between CNPs Regions
Current Bioinformatics Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging p53: Fighting Cancer
Current Cancer Drug Targets Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Palifermin in theManagement of Mucositis in Hematological Malignancies: Current Evidences and Future Perspectives
Cardiovascular & Hematological Agents in Medicinal Chemistry Mucoadhesive Polymers for Delivery of Drugs to the Oral Cavity
Recent Patents on Drug Delivery & Formulation The Type II Transmembrane Serine Protease, Matriptase-2: Possible Links to Cancer?
Anti-Cancer Agents in Medicinal Chemistry EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Current Cancer Drug Targets A Single Center Phase II Study of Continuous Infusion of Low-dose 5- fluorouracil for Heavily Pretreated Patients With Metastatic Colorectal Cancer
Clinical Cancer Drugs